Cheryl S. Hankin, Ph.D
President and Chief Scientific Officer
Dr. Cheryl Hankin is the founder of BioMedEcon and serves as the company’s president and chief scientific officer. She is a respected leader in health economics, with more than 25 years of experience in the field. Her passion to affect positive change in healthcare is the driving force behind the success of BioMedEcon.
Dr. Hankin’s experience in Health Economics and Outcomes Research spans the pharmaceutical industry (Director of Outcomes Research at Johnson and Johnson companies), academia (Assistant Professor at Boston University School of Public Health) and the public sector (Research Health Scientist at the Department of Veterans Affairs, Health Services Research and Development Center of Excellence).
Dr. Hankin graduated from Wellesley College with highest academic honors (Wellesley College Scholar) before earning her doctorate in clinical psychology from Pacific Graduate School of Psychology. She was recently appointed to the Boston University School of Public Health Center for the Assessment of Pharmaceutical Practices (CAPP) and Pharmaceutical Assessment, Management and Policy (PAMP) Advisory Committees.
Prior to entering the healthcare field, Dr. Hankin served as a corporate controller to Silicon Valley industry, during which she provided expertise in conducting financial analyses, forecasting, budgeting, and competitive market evaluations. She therefore has an in-depth understanding of the scientific and business strategies that are required for successful commercialization of health care products.